Imperial College and Francis Crick Institute Spin Out Cancer Company
Novartis (NYSE: NVS) acquires UK biotech firm GenoCure in $1.5bn deal, aiming to bolster oncology pipeline amid rising R&D costs. The target, spun from Imperial College and Francis Crick Institute ... Read More